The number of people with susceptibility test result for rifampicin in Hungary
Hungary: The number of people with susceptibility test result for rifampicin was 84.02 in 2021. ▼ Falling
Latest (2021)
84.02
Change on year
down 1.4%
World rank
88th
of 146 countries
All-time high
92.35
in 2018
All-time low
84.02
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Hungary, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Hungary is 84.02, measured in 2021. That is the lowest value across all 5 years on record.
That represents a change of down 1.4% on the previous year and down 6.9% over five years.
Hungary ranks 88th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Hungary, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 90.25 | — |
| 2018 | 92.35 | +2.3% |
| 2019 | 88.69 | -4.0% |
| 2020 | 85.25 | -3.9% |
| 2021 | 84.02 | -1.4% |
Hungary compared with similar countries
- Hungary's 84.02 is below the median for high income countries, which is 92.6, 91% of the median. (56 countries reporting)
- Hungary's 84.02 is below the median for Europe & Central Asia, which is 93.52, 90% of the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 90.43 | 88.69 | 92.35 | 3 |
| 2020s | 84.63 | 84.02 | 85.25 | 2 |
Countries ranked near Hungary
More health data for Hungary
- Un projection of annual infant deaths, annual growth rate -2.63 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5277 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,225 deaths per 1,000 people (2090)
- Number of infants who die before age 1 37 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.27 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0224 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.2 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Hungary?
- The number of people with susceptibility test result for rifampicin in Hungary was 84.02 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Hungary?
- The highest recorded value was 92.35 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Hungary?
- The lowest recorded value was 84.02 in 2021.
- How does Hungary rank for the number of people with susceptibility test result for rifampicin?
- Hungary ranks 88th out of 146 countries with data for 2021.
- Where does this Hungary data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).